Guangdong WeishitaiHospital Investment & Management Co., Ltd is a subsidiary of Guangzhou WellLead Medical Co., Ltd. It specializes in the field of hospital investment, management,and the field of hemodialysis. The company is committed to lead the operationmode of the mature closed-community dialysis center, and the management system ofdialysis quality treatment, from Guangzhou, an effective starting point to thewhole country. Guangdong Weishitai Hospital Investment & ManagementCo., Ltd is dedicated to providing high-quality dialysis treatment for themajority of patients with kidney disease by using the model of cooperation withlocal hospitals, self-built community of dialysis treatment institutions andintegrated health education and management institutions for patients who havechronic kidney disease.

      In recent years, Chronic KidneyDisease is attracting more and more attention from the Nephrology sector andthe whole medical profession. China’s CKD patients are more than 100 million. Accordingto the statistics, nowadays, the uremic patients who need to accept thedialysis treatment are only one thousandth of the total patients, and patients areincreasing by of two-ten thousandths percent per year. In the past, due to theeconomy and convenience reasons, some uremic patients did not get standardizedhemodialysis treatment according to the patient’s disease condition. Follow-up withopening of national health insurance, reimbursement of about 90% dialysis costs,this greatly alleviates the economic pressure of uremic patients. However, theincrease in the number of patients also highlights the lack of medicalresources. The insufficient of hemodialysis center in domestic, lack of equipment,and the treatment level varied would not be able to meet the requirement of thepatients.

      Guangdong Weishitai HospitalInvestment & Management Co., Ltd, with the support of the Group Company, isactively cooperating with well-known medical institutions in Guangdong Provincewhich converge the best experts in the field of hemodialysis, and provides moreconvenient and high quality dialysis treatment services for the majority ofpatients with kidney disease. Now, the company, in Guangdong Province has got anumber of approvals in the hemodialysis medical institutions in many cities. Meanwhilein other provinces, the company is vigorously to carry out its branch offices.It is believed that in the near future Guangdong Weishitai Hospital Investment& Management Co., Ltd will become the leader in the field of hemodialysistreatment in China, and even the whole Asia.